News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
366,065 Results
Type
Article (14488)
Company Profile (114)
Press Release (351463)
Multimedia
Podcasts (38)
Webinars (7)
Section
Business (112654)
Career Advice (458)
Deals (18613)
Drug Delivery (29)
Drug Development (31189)
Employer Resources (50)
FDA (8797)
Job Trends (7679)
News (172779)
Policy (12362)
Tag
Academia (1324)
Accelerated approval (3)
Allergies (42)
Alliances (34839)
ALS (28)
Alzheimer's disease (520)
Antibody-drug conjugate (ADC) (81)
Approvals (8831)
Artificial intelligence (257)
Autoimmune disease (5)
Automation (14)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (7)
Biosimilars (10)
Biotechnology (86)
Bladder cancer (31)
Brain cancer (13)
Breast cancer (124)
Cancer (1095)
Cardiovascular disease (68)
Career advice (410)
Career pathing (9)
CAR-T (112)
Cell therapy (284)
Cervical cancer (11)
Clinical research (24567)
Collaboration (636)
Compensation (121)
Complete response letters (3)
COVID-19 (1149)
CRISPR (41)
C-suite (154)
Cystic fibrosis (47)
Data (1070)
Decentralized trials (1)
Denatured (18)
Depression (17)
Diabetes (110)
Diagnostics (4931)
Digital health (17)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (77)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (26)
Earnings (38981)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51593)
Executive appointments (425)
FDA (9529)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (501)
Gene editing (94)
Generative AI (25)
Gene therapy (188)
GLP-1 (231)
Government (1237)
Grass and pollen (2)
Guidances (88)
Healthcare (9897)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Indications (13)
Infectious disease (1227)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (33)
Intellectual property (65)
Interviews (52)
IPO (8019)
IRA (8)
Job creations (1439)
Job search strategy (364)
Kidney cancer (4)
Labor market (10)
Layoffs (121)
Leadership (3)
Legal (2521)
Liver cancer (36)
Lung cancer (131)
Lymphoma (67)
Machine learning (7)
Management (17)
Manufacturing (199)
MASH (16)
Medical device (11511)
Medtech (11516)
Mergers & acquisitions (10965)
Metabolic disorders (226)
Multiple sclerosis (31)
NASH (3)
Neurodegenerative disease (34)
Neuropsychiatric disorders (4)
Neuroscience (729)
NextGen: Class of 2025 (3537)
Non-profit (1522)
Now hiring (9)
Obesity (95)
Opinion (78)
Ovarian cancer (42)
Pain (53)
Pancreatic cancer (42)
Parkinson's disease (70)
Partnered (13)
Patents (156)
Patient recruitment (60)
Peanut (26)
People (32830)
Pharmaceutical (16)
Phase I (9065)
Phase II (11085)
Phase III (7188)
Pipeline (665)
Policy (32)
Postmarket research (502)
Preclinical (4117)
Press Release (66)
Prostate cancer (46)
Psychedelics (4)
Radiopharmaceuticals (156)
Rare diseases (139)
Real estate (3366)
Recruiting (20)
Regulatory (9426)
Reports (18)
Research institute (1270)
Resumes & cover letters (68)
Rett syndrome (5)
RNA editing (2)
RSV (23)
Schizophrenia (13)
Series A (90)
Series B (55)
Service/supplier (7)
Sickle cell disease (19)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2509)
State (2)
Stomach cancer (2)
Supply chain (27)
Tariffs (6)
The Weekly (19)
Vaccines (328)
Venture capitalists (19)
Weight loss (35)
Women's health (18)
Worklife (2)
Date
Today (87)
Last 7 days (465)
Last 30 days (1606)
Last 365 days (16989)
2025 (6163)
2024 (18710)
2023 (22098)
2022 (30813)
2021 (32513)
2020 (30539)
2019 (25798)
2018 (19460)
2017 (18877)
2016 (17763)
2015 (20562)
2014 (15177)
2013 (12743)
2012 (13782)
2011 (14066)
2010 (12826)
Location
Africa (320)
Alabama (42)
Alaska (6)
Arizona (125)
Arkansas (10)
Asia (24125)
Australia (4198)
California (3113)
Canada (1084)
China (260)
Colorado (175)
Connecticut (134)
Delaware (49)
Europe (49315)
Florida (516)
Georgia (142)
Idaho (33)
Illinois (295)
India (13)
Indiana (171)
Iowa (5)
Japan (126)
Kansas (85)
Kentucky (7)
Louisiana (7)
Maine (20)
Maryland (480)
Massachusetts (2165)
Michigan (189)
Minnesota (264)
Mississippi (2)
Missouri (62)
Montana (24)
Nebraska (15)
Nevada (26)
New Hampshire (67)
New Jersey (969)
New Mexico (16)
New York (909)
North Carolina (552)
North Dakota (8)
Northern California (1182)
Ohio (107)
Oklahoma (11)
Oregon (20)
Pennsylvania (634)
Puerto Rico (11)
Rhode Island (25)
South America (509)
South Carolina (24)
South Dakota (1)
Southern California (1277)
Tennessee (64)
Texas (503)
United States (12274)
Utah (114)
Virginia (60)
Washington D.C. (13)
Washington State (346)
West Virginia (3)
Wisconsin (41)
366,065 Results for "dynavax technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dynavax Files Preliminary Proxy Statement
April 4, 2025
·
11 min read
Press Releases
Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs
May 7, 2025
·
18 min read
Press Releases
Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum
May 8, 2025
·
15 min read
Press Releases
Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
April 30, 2025
·
13 min read
Press Releases
Dynavax to Participate in Upcoming Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025
April 23, 2025
·
1 min read
Press Releases
Dynavax Advances Board Refreshment Program
January 28, 2025
·
8 min read
Policy
FDA Rejects Dynavax’s Bid to Expand Use of Hepatitis B Vaccine
Dynavax Technologies announced Tuesday that the FDA issued a Complete Response Letter to the company’s sBLA to include a four-dose regimen of Heplisav-B vaccine for adult hemodialysis patients.
May 14, 2024
·
2 min read
·
Kate Goodwin
Biotech Bay
Dynavax to Present at Upcoming June 2024 Investor Conferences
Dynavax Technologies Corporation, a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, announced that the Company will present at the following upcoming investor conferences during the month of June.
May 28, 2024
·
1 min read
Press Releases
Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy
February 19, 2025
·
12 min read
1 of 36,607
Next
